Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Bulletin Du Cancer
|
November 8, 2024
[Cardiovascular adverse effects of Bruton tyrosine kinase inhibitors: Pathophysiological mechanisms, screening, and management]
Jennifer Cautela, Carolyne Croizier, Luca Inchiappa, et al.
Annales De Biologie Clinique
|
April 7, 2025
[Studying daratumumab's interference in serum protein electrophoresis: two case reports]
Alexandre Leonard, Benjamin Bonnet, Carolyne Croizier, et al.
Scientific Reports
|
July 28, 2021
Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis
Jean-Baptiste Bouillon-Minois, Carolyne Croizier, Julien S Baker, et al.
Annals of Hematology
|
January 23, 2025
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors
Manon Garcia, Carolyne Croizier, Grégory Lazarian, et al.
The Lancet. Digital Health
|
April 26, 2024
Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France
Vincent Alcazer, Grégoire Le Meur, Marie Roccon, et al.
Rheumatology (Oxford, England)
|
July 2, 2021
Atypical splice-site mutations causing VEXAS syndrome
Marie Templé, Eugénie Duroyon, Carolyne Croizier, et al.
Nutrients
|
February 26, 2022
The Negative Impact of Night Shifts on Diet in Emergency Healthcare Workers
Jean-Baptiste Bouillon-Minois, David Thivel, Carolyne Croizier, et al.
Journal of Clinical Medicine
|
November 27, 2021
Impact of Air Transport on SpO<sub>2</sub>/FiO<sub>2</sub> among Critical COVID-19 Patients during the First Pandemic Wave in France
Jean-Baptiste Bouillon-Minois, Vincent Roux, Matthieu Jabaudon, et al.
Annals of Hematology
|
April 1, 2025
Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2<sup>V617F</sup> variant allelic fraction in a real-world cohort
Benjamin Lebecque, Carolyne Croizier, Thomas Tassin, et al.
Blood Cancer Journal
|
December 18, 2024
Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM
Florent Malard, Arthur Bobin, Myriam Labopin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Bulletin Du Cancer
|
November 8, 2024
[Cardiovascular adverse effects of Bruton tyrosine kinase inhibitors: Pathophysiological mechanisms, screening, and management]
Jennifer Cautela, Carolyne Croizier, Luca Inchiappa, et al.
Annales De Biologie Clinique
|
April 7, 2025
[Studying daratumumab's interference in serum protein electrophoresis: two case reports]
Alexandre Leonard, Benjamin Bonnet, Carolyne Croizier, et al.
Scientific Reports
|
July 28, 2021
Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis
Jean-Baptiste Bouillon-Minois, Carolyne Croizier, Julien S Baker, et al.
Annals of Hematology
|
January 23, 2025
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors
Manon Garcia, Carolyne Croizier, Grégory Lazarian, et al.
The Lancet. Digital Health
|
April 26, 2024
Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France
Vincent Alcazer, Grégoire Le Meur, Marie Roccon, et al.
Rheumatology (Oxford, England)
|
July 2, 2021
Atypical splice-site mutations causing VEXAS syndrome
Marie Templé, Eugénie Duroyon, Carolyne Croizier, et al.
Nutrients
|
February 26, 2022
The Negative Impact of Night Shifts on Diet in Emergency Healthcare Workers
Jean-Baptiste Bouillon-Minois, David Thivel, Carolyne Croizier, et al.
Journal of Clinical Medicine
|
November 27, 2021
Impact of Air Transport on SpO<sub>2</sub>/FiO<sub>2</sub> among Critical COVID-19 Patients during the First Pandemic Wave in France
Jean-Baptiste Bouillon-Minois, Vincent Roux, Matthieu Jabaudon, et al.
Annals of Hematology
|
April 1, 2025
Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2<sup>V617F</sup> variant allelic fraction in a real-world cohort
Benjamin Lebecque, Carolyne Croizier, Thomas Tassin, et al.
Blood Cancer Journal
|
December 18, 2024
Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM
Florent Malard, Arthur Bobin, Myriam Labopin, et al.
Page
of 3